...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Presentation at AACR Meeting April 10-15

ya  - guess a person could sit around for years with hands in their pockets regarding rv , zen & Bti - not much of a strategy there. I've already moved off Bti , rv next/by June & will give zen till October & that will be the end of my biotech plays.

Share
New Message
Please login to post a reply